{"id":"clm_F13B391E1DBB","entity":"pfizer","predicate":"shares_outstanding","value":"5,606,688,356 shares","value_json":{"fp":"Q2","fy":2021,"accn":"0000078003-21-000093","form":"10-Q","filed":"2021-08-12","period":"Q2 FY2021","concept":"dei:EntityCommonStockSharesOutstanding"},"valid_from":"2021-08-09","valid_to":"2021-11-08","published":"2021-08-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Pfizer shares outstanding: 5,606,688,356 shares\", as of 2021-08-09 (until 2021-11-08). Claim clm_F13B391E1DBB, https://asof.is/claim/clm_F13B391E1DBB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/78003/000007800321000093/0000078003-21-000093-index.htm.","url":"https://asof.is/claim/clm_F13B391E1DBB","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F3A7A466D205","supersedes":["clm_25AD8F550E87"],"first_seen_at":"2026-11-08T16:58:25.959946+00:00","updated_at":"2026-11-08T16:58:33.292523+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/78003/000007800321000093/0000078003-21-000093-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2021, filed 2021-08-12"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}